Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Paal

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Clinical Laboratory|April 8, 2020
Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MSMichael Paal, Katharina Habler, Bernd Northoff, et al.
Microbial Cell Factories|November 25, 2010
Dissection of an old protein reveals a novel application: domain D of Staphylococcus aureus Protein A (sSpAD) as a secretion--tagThomas Heel, Michael Paal, Rainer Schneider, et al.
Clinical Chemistry and Laboratory Medicine|December 24, 2022
Pitfall in the analysis of the alcohol biomarkers ethyl glucuronide and ethyl sulfate by laboratory-caused contamination with disinfectantsKatharina Habler, Michael Paal, Felix Lucian Happich, et al.
European Journal of Clinical Pharmacology|August 19, 2025
Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and metabolic ratio in a naturalistic settingKajetan Nierychlewski, Michael Paal, Sebastian Meinzer, et al.
Journal of Clinical Pharmacy and Therapeutics|December 16, 2020
Comment on: 'Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine' by Tsushita et alIsaac Lean, Michael Paal, Yana Suttmann, et al.
Intensive Care Medicine|February 10, 2023
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failureUwe Liebchen, Michael Paal, Caroline Gräfe, et al.
The Lancet Regional Health. Europe|November 1, 2021
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)Sandra Hasmann, Michael Paal, Louise Füeßl, et al.
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Journal of Visualized Experiments : Jove|September 18, 2018
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical IllnessesCarina Schuster, Sebastian Sterz, Daniel Teupser, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Clinical Laboratory|April 8, 2020
Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MSMichael Paal, Katharina Habler, Bernd Northoff, et al.
Microbial Cell Factories|November 25, 2010
Dissection of an old protein reveals a novel application: domain D of Staphylococcus aureus Protein A (sSpAD) as a secretion--tagThomas Heel, Michael Paal, Rainer Schneider, et al.
Clinical Chemistry and Laboratory Medicine|December 24, 2022
Pitfall in the analysis of the alcohol biomarkers ethyl glucuronide and ethyl sulfate by laboratory-caused contamination with disinfectantsKatharina Habler, Michael Paal, Felix Lucian Happich, et al.
European Journal of Clinical Pharmacology|August 19, 2025
Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and metabolic ratio in a naturalistic settingKajetan Nierychlewski, Michael Paal, Sebastian Meinzer, et al.
Journal of Clinical Pharmacy and Therapeutics|December 16, 2020
Comment on: 'Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine' by Tsushita et alIsaac Lean, Michael Paal, Yana Suttmann, et al.
Intensive Care Medicine|February 10, 2023
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failureUwe Liebchen, Michael Paal, Caroline Gräfe, et al.
The Lancet Regional Health. Europe|November 1, 2021
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)Sandra Hasmann, Michael Paal, Louise Füeßl, et al.
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Journal of Visualized Experiments : Jove|September 18, 2018
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical IllnessesCarina Schuster, Sebastian Sterz, Daniel Teupser, et al.
Pageof 7